Translucence Biosystems recently took part in the Keystone meeting, "Drug Delivery to the Brain: Challenges and Progress," which was held in Breckinridge, CO from January 23-26, 2023. Our team collaborated with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. The CEO of Translucence Biosystems, Damian Wheeler, Ph.D., presented the findings in a poster titled "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."

The Keystone meeting provided a valuable opportunity for Translucence Biosystems to network with industry leaders and stay informed about the latest advancements in drug delivery research. We are grateful for the support of event organizers, Robert Thorne from Denali Therapeutics and Reina Bendayan from the University of Toronto.

Download a copy of our poster here.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

1. Item 1
2. Item 2
3. Item 3

Unordered list

• Item A
• Item B
• Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript